An Exploratory Study of JNS004 (Nesiritide) in Patients With Acute Heart Failure (J2).
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2014
At a glance
- Drugs Nesiritide (Primary)
- Indications Acute heart failure
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutica
- 29 Jan 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 29 Jan 2009.
- 29 Jan 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 29 Jan 2009 Actual patient numbers (67) added as reported by ClinicalTrials.gov.